Isis Pharma (ISIS) Issues Positive Update on ISIS-PKKRx Phase 1
Tweet Send to a Friend
Isis Pharma (NASDAQ: ISIS) announced positive results from a Phase 1 study with ISIS-PKKRx. In this study, healthy volunteers ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
